Список литературы

1. Scully R.E., Young R.H., Clement P.B. Tumor like lesions. Tumors of the ovary and maldeveloped gonads, fallopian tube and broad ligament. Washington: Armed Forces Institute of Pathology, 1998. Pp. 443 - 444.

2. Shih I.M., Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004; 164(5): 1511 - 8.

3. Shih I.M., Kurman R.J. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 2005; 11(20): 7273 - 9.

4. Kempson R.L., Hendrickson M.R. Ovarian serous borderline tumors: the citadel defended. Hum Pathol 2000; 31(5): 525 - 6.

5. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005; 123 (Suppl.): 13 - 57.

6. International Statistical Classification of Diseases and Related Health Problems. 10th Revision.

7. WHO Classification of Tumours of Female Reproductive Organs. 4th edn. Lyon: IARS, 2014. 307 p.

8. Ayhan A., Akarin R., Develioglu O. et al. Borderline epithelial ovarian tumors. Aust N Z J Obstet Gynecol 1991; 31(2): 174 - 6.

9. Губина О.В. Особенности клинического течения и лечения пограничных опухолей яичников. Автореф. дис. ... канд. мед. наук. М., 1995.

10. Ledermann J.A., Raja F.A., Fotopoulou C. et al. Newly Diagnosed and Relapsed Epithelial Ovarian Carcinoma: ESMO Clinical Practice Guidelines//Ann Oncol. - 2013. - V. 24 (Suppl 6). - P. vi24 - vi32.

11. Давыдова И.Ю., Карселадзе А.И., Кузнецов В.В. и др. Практические рекомендации по лекарственному лечению пограничных опухолей яичников. Злокачественные опухоли: практические рекомендации RUSSCO, 2018 г. Т. 8. С. 171 - 177.

12. Ebell M.H., Culp M.B., Radke T.J. A systematic review of symptoms for the diagnosis of ovarian cancer. Am J Prev Med 2016; 50(3): 384 - 94.

13. NCCN guidelines panel. Epithelial ovarian cancer (including fallopian tube cancer and primary peritoneal cancer). Version 1.2016. Available at: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#ovarian.

14. Stiekema A., Boldingh Q.J., Korse C.M. et al. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin. Gynecol Oncol 2015; 136(3): 562 - 6.

15. Santotoribio J.D., Garcia de la Torre A., C. et al. Cancer antigens 19.9 and 125 as tumor markers in patients with mucinous ovarian tumors. Eur J Gynaecol Oncol 2016; 37(1): 26 - 9.

16. Colombo N., Peiretti M., Garbi A. et al. Non-Epithelial Ovarian Cancer: ESMO Clinical Practice Guidelines. Ann Oncol 2012; 23 (Suppl 7): vii20 - 6.

17. Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health 2014; 80(5): 412 - 7.

18. Ledermann J.A., Raja F.A., Fotopoulou C. et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines. Ann Oncol 2013; 24 (Suppl 6): vi24 - 32.

19. Stuart G., Kitchener H., Bacon M. et al. 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on clinical trials in ovarian cancer. Int J Gynecol Cancer 2011; 21: 750Y755.

20. Trimbos J.B., Parmar M., Vergote I. et al. International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003; 95(2): 105 - 12.

21. Rooth C. Ovarian cancer: risk factors, treatment and management. Br J Nurs 2013; 22(17): S23 - 30.

22. NCCN Guidelines Version 1.2019 Ovarian Borderline Epithelial Tumors. Available at: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#ovarian.

23. Vasconcelos I. Management of borderline ovarian tumors state of the art. Uterus & Ovary 2015; 2: 1 - 6. DOI: 10.14800/uo.885.

24. Vasconcelos I. Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence risk. Eur J Cancer 2015; 51(5): 620 - 31.

25. Camatte S., Morice P., Thoury A. et al. Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 2004; 40(12): 1842 - 9.

26. Новикова Е.Г., Баталова Г.Ю. Пограничные опухоли яичников. М.: Медицинское информационное агентство, 2007. 152 с.

27. Trillsch F. Mahner S., Ruetzel J.D. et al. Clinical management of borderline ovarian tumors. Expert Rev Anticancer Ther 2010; 10(7): 1115 - 24.

28. Новикова Е.Г., Шевчук А.С., Завалишина Л.Э. Некоторые аспекты органосохраняющего лечения пограничных опухолей яичников. Российский онкологический журнал 2010; (4): 15 - 20.

29. Ushijima K., Kawano K., Tsuda N. et al. Epithelial borderline ovarian tumor: Diagnosis and treatment strategy. Obstet Gynecol Sci 2015; 58(3): 183 - 7.

30. Kleppe M., Bruls J., van Gorp T. et al. Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature Gynecol. Oncol 2014; 133(2): 155 - 8.

31. Morice P., Camatte S., Wicart-Poque F. et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod 2003; 9(2): 185 - 92.

32. Карселадзе А.И. К морфологии муцинозных пограничных опухолей яичников. Архив патологии 1989; 51(5): 40 - 6.

33. Du Bois A., Ewald-Riegler N., du Bois O., Harter P. Borderline tumors of the ovary: a systematic review. Geburtsh Frauenheilk 2009; 69: 807 - 33.

34. Абузарова Г.Р., Арутюнов Г.П. Хронический болевой синдром (ХБС) у взрослых пациентов, нуждающихся в паллиативной медицинской помощи. Клинические рекомендации, 2018 г.

35. Silver J.K., Baima J. Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil 2013; 92(8): 715 - 27.

36. Nilsson H., Angeras U., Bock D., M., Onerup A., Fagevik Olsen M., Gellerstedt M., Haglind E., Angenete E. Is preoperative physical activity related to post-surgery recovery? BMJ Open. 2016 Jan 14; 6(1): e007997. doi: 10.1136/bmjopen-2015-007997.

37. Tsimopoulou I., Pasquali S., Howard R., Desai A., Gourevitch D., Tolosa I., Vohra R. Psychological Prehabilitation Before Cancer Surgery: A Systematic Review. Ann Surg Oncol. 2015 Dec; 22(13): 4117 - 23. doi: 10.1245/s10434-015-4550-z. Epub 2015 Apr 14.

38. Nelson G., Bakkum-Gamez J., Kalogera E. et al Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations - 2019 update International Journal of Gynecologic Cancer Published Online First: 15 March 2019. doi: 10.1136/ijgc-2019-000356.

39. Wren S.M., Martin M., Yoon J.K., Bech F. Postoperative pneumonia-prevention program for the inpatient surgical ward//Journal of the American College of Surgeons. - 2010. - Vol. 210, No. 4 - pp. 491 - 495.

40. Goerling U., Jaeger C., Walz A. et al. The efficacy of psycho-oncological interventions for women with gynaecological cancer: A randomized study//Oncology. 2014; 87: 114 - 124. Crossref, Medline.

41. Shehadeh A., El Dahleh M., Salem A. et al. Standardization of rehabilitation after limb salvage surgery for sarcomas improves patients' outcome. Hematol Oncol Stem Cell Ther 2013; 6 (3 - 4): 105 - 11.

42. Marchese V.G., Spearing E., Callaway L. et al. Relationships among range of motion, functional mobility, and quality of life in children and adolescents after limb-sparing surgery for lower-extremity sarcoma. Pediatr Phys Ther 2006; 18(4): 238 - 44.

43. Cox C.L., Montgomery M., Oeffinger K.C. et al. Promoting physical activity in childhood cancer survivors: results from the Childhood Cancer Survivor Study. Cancer 2009; 115(3): 642 - 54.

44. Tinelli F., Tinelli R., La Grotta F. et al. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors. Acta Obstet Gynecol Scand 2007; 86(1): 81 - 7.

45. Mooney J., Silva E., Tornos C. et al. Unusual features of serous neoplasms of low malignant potential during pregnancy. Gynecol Oncol 1997; 65(1): 30 - 5.

46. Kaern J., C.G., Abeler V.M. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer 1993; 71(5): 1810 - 20.

47. Morice P., Camatte S., Wicart-Poque F. et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update 2003; 9(2): 185 - 92.

48. Fischerova D. et al. Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study//Ultrasound in Obstetrics & Gynecology. - 2017. - T. 49. - N. 2. - C. 263 - 274.

49. Oken M.M., Creech R.H., Tormey D.C. et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5(6): 649 - 55.

50. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of chemotherapeutic agents. edn. Edited by MacLeod C. New York: Columbia University Press; 1949: 191 - 205.